Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ.
about
Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Ductal Carcinoma In SituIs the false-positive rate in mammography in North America too high?Population-based screening for cancer: hope and hype.Cause-specific Mortality in a Population-based Cohort of 9799 Women Treated for Ductal Carcinoma In Situ.Utilization of Axillary Surgery for Patients With Ductal Carcinoma In Situ: A Report From the National Cancer Data Base.Effect of Referral Patterns and Treatment Type on Oncologic Outcomes for Women with Ductal Carcinoma In Situ.Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma In Situ.DCIS and axillary nodal evaluation: compliance with national guidelines.A meta-analysis of randomized controlled trials comparing the efficacy and safety of anastrozole versus tamoxifen for breast cancerAnastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trialOutcomes of Active Surveillance for Ductal Carcinoma in Situ: A Computational Risk AnalysisClinical Utility of the 12-Gene DCIS Score Assay: Impact on Radiotherapy Recommendations for Patients with Ductal Carcinoma In Situ.Emerging trends in surgical and adjuvant radiation therapies among women diagnosed with ductal carcinoma in situPrediction of invasive breast cancer using shear-wave elastography in patients with biopsy-confirmed ductal carcinoma in situ.Adjuvant radiotherapy versus observation following lumpectomy in ductal carcinoma in-situ: A meta-analysis of randomized controlled trials.Trends in adjuvant therapies after breast-conserving surgery for hormone receptor-positive ductal carcinoma in situ: findings from the National Cancer Database, 2004-2013.Family history and risk of breast cancer: an analysis accounting for family structureContralateral Breast Cancer Risk in Women with Ductal Carcinoma In Situ: Is it High Enough to Justify Bilateral Mastectomy?Recurrence risk perception and quality of life following treatment of breast cancer.Cause-specific mortality in women with breast cancer in situ.Benefit of low-dose tamoxifen in a large observational cohort of high risk ER positive breast DCIS.Risk prediction for local versus regional/metastatic tumors after initial ductal carcinoma in situ diagnosis treated by lumpectomy.Ductal Carcinoma In Situ Biology, Biomarkers, and Diagnosis.Trends and clinicopathological predictors of axillary evaluation in ductal carcinoma in situ patients treated with breast-conserving therapy.Local delivery of hormonal therapy with silastic tubing for prevention and treatment of breast cancer.Sentinel node biopsy in ductal carcinoma in situ of the breast: Never justified?Co-expression of p16 and p53 characterizes aggressive subtypes of ductal intraepithelial neoplasia.Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma in Situ.Margins in DCIS: Does Residual Disease Provide an Answer?Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells.Trends and outcomes of neoadjuvant radiotherapy compared with postoperative radiotherapy for malignant breast cancer.Patterns of Practice in Radiotherapy for Breast Cancer in Korea
P2860
Q28075837-90048F21-91CA-4DA2-BE2E-D8712C682440Q30250289-77B0EF0A-3D9D-4190-994B-034BFD2FE055Q30251601-3ECEFE49-D73B-445D-A949-8C061B776243Q30491311-FECA2195-A7B3-4129-B59F-D0E2675576EEQ31110118-3C3B9EAA-9682-40CA-9441-A0788CE6AF5AQ33617264-D0DEC04F-5A7E-4064-97A2-F40C84F081DFQ33816606-4F076D71-835E-4200-815E-BDFEB87DD558Q36273345-378FB844-EA2A-4F3E-82D7-ADB3F277A3D4Q36348871-1F2C05A1-149B-4E3D-AAE7-21622E18A2C1Q36625021-4E605078-E142-42A9-9916-1148C0ACE4FCQ36849147-5FE90FF3-FA22-4403-9DED-C3F6F02DC983Q37639243-4EAE204C-C00E-43D6-958B-D92D83174440Q38407639-DF09EB51-51AD-4775-8ECE-F24A89EE0A2FQ38415331-581B3FD3-FB91-49EF-801B-C503C58B9C2EQ38611952-83314F74-C172-4A27-9F7B-F441D26674F6Q38641730-0B0AE01B-A6B4-465F-AE7F-F13C67C23120Q38746332-11435F19-3426-479E-BBD6-77E82E2E47BCQ40098508-02247428-67E5-464C-BC04-CCA11988E33DQ40412658-D1208D76-DF35-4192-B292-82083A88201DQ40595247-E6F02555-6D97-4903-AE31-2AD3C686EEABQ40665794-72EB4ADB-B938-4C6F-8C6C-824644C6DCD9Q40768655-99B7A31B-2DFF-4ECC-A4F3-11634F5A379FQ46699535-A147993D-D192-4909-818A-8D45EE6D34E7Q47186651-32C1AD1F-0321-48F3-94B9-BBC9D3E22698Q47192770-AFF9E7F5-5BF9-443C-A5E4-D8751803025EQ47811783-C9F1FC1D-B94F-4712-BEB3-068372D838F5Q51467842-8E702A88-4552-4006-A06D-75984DA2021EQ53046041-0BDC4266-F2DB-4F60-B8E8-3A5CFC9806D6Q54295810-3A1CB011-1B6D-4776-AF95-2124DA55164BQ55251624-40A09C6E-9CAB-4CE5-9BCD-3E28780CC22BQ55328472-F07DAC19-1C9B-4B88-9464-B7F4771DBC73Q57124865-188517B6-1D74-4B4A-A355-8AA08D73FB5F
P2860
Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ.
@ast
Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ.
@en
type
label
Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ.
@ast
Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ.
@en
prefLabel
Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ.
@ast
Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ.
@en
P2093
P2860
P356
P1476
Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ.
@en
P2093
Deba Sarma
E Shelley Hwang
Evan R Myers
Igor Akushevich
Marc D Ryser
Rachel Greenup
P2860
P304
P356
10.1093/JNCI/DJV263
P407
P577
2015-09-30T00:00:00Z